This article reviews comparative evidence on different Chinese patent medicines added to SSRIs for depressive disorder, helping readers judge study types and comparisons.
Key Takeaways
- Combining Chinese patent medicines with SSRIs significantly improved depressive symptoms compared with SSRIs alone
- Jieyu Wan (JYW)+SSRIs ranked highest for HAMD improvement
- Safety profiles showed no statistically significant differences in adverse drug reactions